Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basimglurant adjunctive therapy trial in pediatric and adolescent TSC-associated uncontrolled seizures
MOH_2021-10-25_010347Phase 2Recruiting
- Sponsor
- Noema Pharma
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of basimglurant in tuberous sclerosis complex (TSC) (3 arms), sponsored by Noema Pharma. Started Oct 2021; status: recruiting.
02
Drugs
basimglurant
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on MOH_2021-10-25_010347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-10-25_010347.